The important role of non-covalent drug-protein interactions in drug hypersensitivity reactions.

allo-immunity drug hypersensitivity fake antigen heterologous immunity virus reactivation

Journal

Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028

Informations de publication

Date de publication:
02 2022
Historique:
revised: 14 05 2021
received: 11 03 2021
accepted: 20 05 2021
pubmed: 27 5 2021
medline: 9 4 2022
entrez: 26 5 2021
Statut: ppublish

Résumé

Drug hypersensitivity reactions (DHR) are heterogeneous and unusual immune reactions with rather unique clinical presentations. Accumulating evidence indicates that certain non-covalent drug-protein interactions are able to elicit exclusively effector functions of antibody reactions or complete T-cell reactions which contribute substantially to DHR. Here, we discuss three key interactions; (a) mimicry: whereby soluble, non-covalent drug-protein complexes ("fake antigens") mimic covalent drug-protein adducts; (b) increased antibody affinity: for example, in quinine-type immune thrombocytopenia where the drug gets trapped between antibody and membrane-bound glycoprotein; and (c) p-i-stimulation: where naïve and memory T cells are activated by direct binding of drugs to the human leukocyte antigen and/or T-cell receptors. This transient drug-immune receptor interaction initiates a polyclonal T-cell response with mild-to-severe DHR symptoms. Notable complications arising from p-i DHR can include viral reactivations, autoimmunity, and multiple drug hypersensitivity. In conclusion, DHR is characterized by abnormal immune stimulation driven by non-covalent drug-protein interactions. This contrasts DHR from "normal" immunity, which relies on antigen-formation by covalent hapten-protein adducts and predominantly results in asymptomatic immunity.

Identifiants

pubmed: 34037262
doi: 10.1111/all.14962
pmc: PMC9291849
doi:

Substances chimiques

HLA Antigens 0
Haptens 0
Receptors, Antigen, T-Cell 0
Receptors, Immunologic 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

404-415

Informations de copyright

© 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Références

J Invest Dermatol. 1994 Jun;102(6):28S-30S
pubmed: 8006430
Int Arch Allergy Immunol. 2017;172(3):129-138
pubmed: 28315874
Lancet. 2002 Mar 2;359(9308):727-32
pubmed: 11888582
J Immunol. 2000 Jun 15;164(12):6647-54
pubmed: 10843725
J Allergy Clin Immunol. 2002 Jan;109(1):155-61
pubmed: 11799383
Nature. 2012 Jun 28;486(7404):554-8
pubmed: 22722860
J Allergy Clin Immunol. 2011 Dec;128(6):1266-1276.e11
pubmed: 21924464
Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):E4792-E4801
pubmed: 28572406
N Engl J Med. 2013 Oct 24;369(17):1620-8
pubmed: 24152261
J Exp Med. 1994 Apr 1;179(4):1155-61
pubmed: 7511682
PLoS One. 2015 Feb 12;10(2):e0117160
pubmed: 25674793
Front Immunol. 2019 Jun 19;10:1358
pubmed: 31281313
Allergy. 2007 Dec;62(12):1474-5
pubmed: 17983386
Blood. 1998 Oct 1;92(7):2366-73
pubmed: 9746776
Br J Dermatol. 1997 Oct;137(4):605-8
pubmed: 9390340
AIDS. 2012 Jul 17;26(11):F21-9
pubmed: 22617051
Allergy. 2020 Jun;75(6):1300-1315
pubmed: 31749148
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4134-9
pubmed: 15743917
J Immunol. 2015 Aug 1;195(3):1282-92
pubmed: 26085679
Toxicology. 2001 Feb 2;158(1-2):11-23
pubmed: 11164988
Allergy. 2002 Oct;57(10):884-93
pubmed: 12269933
Allergy. 2022 Feb;77(2):404-415
pubmed: 34037262
J Exp Med. 1936 Sep 30;64(4):625-39
pubmed: 19870557
Int Arch Allergy Immunol. 2015;168(1):13-24
pubmed: 26524432
N Engl J Med. 2008 Feb 7;358(6):568-79
pubmed: 18256392
Allergy. 2007 Dec;62(12):1439-44
pubmed: 17983378
Br J Dermatol. 2007 Nov;157(5):989-96
pubmed: 17854366
J Allergy Clin Immunol. 2006 Feb;117(2):455-62
pubmed: 16461148
Blood Rev. 2010 Jul-Sep;24(4-5):143-50
pubmed: 20650555
Br J Dermatol. 2006 Aug;155(2):301-6
pubmed: 16882166
Front Immunol. 2020 Oct 08;11:580483
pubmed: 33117387
Australas J Dermatol. 2017 Aug;58(3):e61-e67
pubmed: 27040133
J Clin Med. 2020 Jul 13;9(7):
pubmed: 32668640
Int Immunol. 2001 Jul;13(7):877-85
pubmed: 11431418
Br J Dermatol. 2007 May;156(5):1083-4
pubmed: 17381452
Contact Dermatitis. 2015 Jan;72(1):2-10
pubmed: 25348820
J Clin Invest. 1998 Oct 15;102(8):1591-8
pubmed: 9788973
J Allergy Clin Immunol. 2013 Sep;132(3):756-758
pubmed: 23706613
J Allergy Clin Immunol. 2018 Jan;141(1):235-249.e8
pubmed: 28219704
Ann Pharmacother. 2008 Mar;42(3):387-96
pubmed: 18303141
Curr Allergy Asthma Rep. 2003 Jan;3(1):1-3
pubmed: 12542986
Immunogenetics. 2017 Aug;69(8-9):631-641
pubmed: 28718002
Eur J Dermatol. 2009 Jul-Aug;19(4):325-32
pubmed: 19447733
Annu Rev Immunol. 2002;20:197-216
pubmed: 11861602
Chem Res Toxicol. 2019 Oct 21;32(10):2095-2106
pubmed: 31468968
Int Immunol. 1998 Apr;10(4):507-15
pubmed: 9620607
J Eur Acad Dermatol Venereol. 2008 Sep;22(9):1044-9
pubmed: 18627428
Nat Rev Immunol. 2007 Dec;7(12):942-53
pubmed: 18007679
Nat Rev Drug Discov. 2011 Apr;10(4):307-17
pubmed: 21455239
Chem Res Toxicol. 2017 Jan 17;30(1):295-314
pubmed: 27775332
Br J Dermatol. 2013 Nov;169(5):1071-80
pubmed: 23855313
Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9959-64
pubmed: 22645359
Methods Mol Biol. 2021;2197:51-85
pubmed: 32827132
Nat Rev Immunol. 2010 Nov;10(11):753-66
pubmed: 20972472
Ann N Y Acad Sci. 2007 Oct;1114:23-35
pubmed: 17986574
J Dermatol. 2015 Mar;42(3):276-82
pubmed: 25623158
PLoS One. 2014 Apr 21;9(4):e95339
pubmed: 24751900
Curr Opin Allergy Clin Immunol. 2002 Aug;2(4):301-5
pubmed: 12130944
Toxicol Sci. 2020 Nov 1;178(1):115-126
pubmed: 32777075
J Immunol. 2001 Mar 15;166(6):3837-45
pubmed: 11238627
Dermatopathology (Basel). 2019 Jun 26;6(2):111-125
pubmed: 31700852
Clin Exp Dermatol. 2010 Dec;35(8):863-8
pubmed: 20456395
J Thromb Haemost. 2009 Jun;7(6):911-8
pubmed: 19344362
Clin Exp Allergy. 2013 Sep;43(9):1027-37
pubmed: 23957338
J Virol. 2020 Oct 27;94(22):
pubmed: 32878893
PLoS One. 2013 Oct 07;8(10):e76211
pubmed: 24116097
J Clin Invest. 1997 Jul 1;100(1):136-41
pubmed: 9202065
J Exp Med. 2005 Sep 5;202(5):673-85
pubmed: 16147978
Allergol Int. 2006 Mar;55(1):17-25
pubmed: 17075282
Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):369-75
pubmed: 22729028
Int Arch Allergy Immunol. 2016;171(3-4):166-179
pubmed: 27960170
J Clin Invest. 2018 Jul 2;128(7):2819-2832
pubmed: 29782330
J Invest Dermatol. 2004 Nov;123(5):850-5
pubmed: 15482470
J Allergy Clin Immunol. 2004 Nov;114(5):1209-15
pubmed: 15536433
J Biomol Struct Dyn. 2016 Aug;34(8):1806-17
pubmed: 26488421
Blood. 2015 Oct 29;126(18):2138-45
pubmed: 26282540
Clin Transl Allergy. 2020 Nov 23;10(1):52
pubmed: 33292540
Molecules. 2015 Jan 27;20(2):1984-2000
pubmed: 25633330
Allergy. 2020 May;75(5):1178-1187
pubmed: 31814130
Nat Commun. 2019 Aug 8;10(1):3569
pubmed: 31395875
Chem Res Toxicol. 2011 Sep 19;24(9):1345-410
pubmed: 21702456
Immunol Allergy Clin North Am. 2009 Aug;29(3):481-501
pubmed: 19563993
Blood. 2008 Feb 1;111(3):1234-9
pubmed: 17959856
Immunohematology. 2014;30(2):55-65
pubmed: 25247620
Br J Pharmacol. 2001 Feb;132(3):623-30
pubmed: 11159714
Immunology. 2001 Jan;102(1):8-14
pubmed: 11168631
Mol Pharmacol. 2006 Jul;70(1):356-65
pubmed: 16617162
Methods Mol Biol. 2021;2183:1-8
pubmed: 32959236
Allergy. 2021 May;76(5):1340-1349
pubmed: 32780486
J Allergy Clin Immunol. 2004 Mar;113(3):519-27
pubmed: 15007356
J Immunol. 1999 Jan 1;162(1):595-602
pubmed: 9886437
Front Pharmacol. 2020 Jul 02;11:969
pubmed: 32714190
Allergy. 2012 Jan;67(1):58-66
pubmed: 21933197
Allergy. 2020 Apr;75(4):781-797
pubmed: 31758810
Clin Exp Allergy. 2002 Nov;32(11):1635-43
pubmed: 12569986
J Immunol. 1997 Feb 1;158(3):1139-48
pubmed: 9013953
J Immunol. 2017 Jun 1;198(11):4217-4227
pubmed: 28438900
J Clin Invest. 1996 Sep 1;98(5):1158-64
pubmed: 8787679
Int J Infect Dis. 2020 Nov;100:239-246
pubmed: 32891735
J Allergy Clin Immunol. 2019 Jul;144(1):183-192
pubmed: 30776417
Curr Allergy Asthma Rep. 2016 Mar;16(3):17
pubmed: 26810177
Nat Med. 2000 Dec;6(12):1348-54
pubmed: 11100119
J Immunol. 2014 Apr 1;192(7):2984-93
pubmed: 24591375
J Invest Dermatol. 2002 Apr;118(4):728-33
pubmed: 11918724
Nature. 2004 Apr 1;428(6982):486
pubmed: 15057820
Nat Rev Immunol. 2002 Jun;2(6):417-26
pubmed: 12093008

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH